TESLA Stroke Trial

The TESLA trial @oozaidat @AlbertJYoo jamanetwork.com/journals/jama/…

Practical recommendations on selection of patients with large infarct for thrombectomy from @svinsociety @SVINJournal Keeping it simple approach minimizes delays to treatment ⌛️= 🧠 ahajournals.org/doi/10.1161/SV…

From @JAMA_current: Among pts with a large infarct on noncontrast CT presenting within 24 hours, thrombectomy did not demonstrate improvement in functional outcomes at 90 days vs medical care alone; findings were not definitive & further study is needed. ja.ma/4dnjQhk

Congratulation. It was an honor to be part of this historical trial. @TESLATrial @oozaidat @NMNeurology @NorthwesternMed

This would have not happened without the dedication of all Tesla sites investigators, coordinators and academic-industry partnership.

jamanetwork.com/journals/jama/… @oozaidat @AlbertJYoo TESLA Trial is out!

jamanetwork.com/journals/jama/… The final results of TESLA trial are out @TESLATrial @oozaidat

CT Selected Thrombectomy vs Medical Management for Late Anterior LVO @RaulNogueiraMD MMQ @AbdalkaderMD @NagelSimon @RaymondJeanMD1 @Puetz_Volker @SunilAShethMD @marcriboj @martaoliveg @TudorGJovin @JimSiegler @DiogoHaussen @Mahmoudneuro @CerebrovascLab neurology.org/doi/10.1212/WN…

Humbled to have co-led this trial showing benefit of MT in early presenting pts with unlimitedly large infarcts. Large core regardless of size = poor prognosis, but not treatment effect modifier. IMAGING CANNOT IDENTIFY PTS WHO DON'T BENEFIT FROM MT !! nejm.org/doi/full/10.10…

💥Newest updates in large core💥Analysis of 60+ centers from the #CLEAR study shows benefit of EVT in real-world❗️ patients with large ischemic core (ASPECTS 0-5). Sincere thanks to all the collaborators on their great efforts! journals.sagepub.com/doi/10.1177/23…

@adnan_mujanovic @CheesemakerMD @NguyenThanhMD @ESOstroke Congratulation. Great work. Impressive sample size and real life experience.

Dr.Osama Zaidat @oozaidat presenting One-Year Outcome for TESLA #ISC24

Thank you @Medscape Indeed, @TESLATrial results are in the same direction. It’s the totally of evidence that we should evaluate. Looking forward to @TENSIONstudy & LASTE results to update MAGNA and provide the field with the highest level of evidence medscape.com/viewarticle/99…

Mechanical Thrombectomy for Large Ischemic Stroke: A Systematic Review and Meta-Analysis n.neurology.org/content/early/…

#ResearchTuesday: @TESLATrial by @oozaidat @AlbertYoo et al, the latest #largecoreinfarct #RCT using NCCT #ASPECTS only, suggests #thombectomy yields benefit on 90d mRS 0-3 vs best medical mgmt. doi.org/10.1161/SVIN.1…

.@AlbertJYoo and @oozaidat presented @TESLATrial data at #ESOC2023, reporting a “strong suggestion” #EVT can provide benefits vs standard care in large-core infarct #Stroke—despite falling short of its primary endpoint @ESOstroke #Thrombectomy #StrokeCare neuronewsinternational.com/tesla-trial-mi…

TESLA Trial: Rationale, Protocol, and Design | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV… @oozaidat @AlbertJYoo et al

For those who missed our ESOC Session on TESLA Large core infarct randomized trial (ASPECTS 2-5 on CT) comparing thrombectomy vs medical therapy, here is 1 slide and a tribute to everyone who was part of the trial. Sam and Albert. ⁦@oozaidat⁩ @AlbertJYoo⁩

For those who missed ESOC Session on TESLA Large core infarct randomized trial (defined using ASPECTS 2-5 on CT scan) comparing thrombectomy vs medical therapy results. One slide of the results and attribute to everyone who was part of the trial. Sam and Albert @AlbertJYoo